TRAF1 and post-transplant lymphoproliferative disease: TRAF1 is abundantly expressed in EBV-infected immunoblasts in patients with infectious mononucleosis [47], and is also highly expressed in EBV-associated PTLD and Hodgkin lymphoma, where TRAF1 serves as an important biomarker [47,48,49].